GlySens is developing an implantable, long-term continuous glucose monitoring sensor designed to provide a wireless means to track glucose levels and improve the lives of people with diabetes. The sensor resides completely under the skin and transmits glucose measurements wirelessly to a convenient external display device, so patients may control their blood sugar levels more effectively.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/12/12 | undisclosed |
West Health Investment Fund | undisclosed |
